Last reviewed · How we verify

NCT01706588: DP4

Preliminary Evaluation of the Efficacy and Local Tolerability of Injectable Diclofenac at 5, 12.5, 25 and 50 mg/mL, Administered Locally Prior to Surgery for the Prevention of Post-operative Pain After Third Molar Surgery

Completed Phase 2 Results posted Last updated 28 August 2014
What this trial tests

Phase 2 trial testing Diclofenac sodium in Pain in 75 participants. Completed in 1 May 2013.

Timeline
1 January 2013
Primary endpoint
1 May 2013
1 May 2013

Quick facts

Lead sponsorIBSA Institut Biochimique SA
PhasePhase 2
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment75
Start date1 January 2013
Primary completion1 May 2013
Estimated completion1 May 2013
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

IBSA Institut Biochimique SA — full company profile →

Who can join

Adults 18 to 65, any sex, with Pain. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Sponsor's own description

This is a prospective, randomised, double-blind, placebo-controlled, parallel group study in approximately 75 patients undergoing surgical removal of an impacted lower third molar.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Submucosal Diclofenac for Acute Postoperative Pain in Third Molar Surgery: A Randomized, Controlled Clinical Trial.
    Gorecki P, Rainsford KD, Taneja P, Bulsara Y, et al · · 2018 · cited 12× · PMID 29202646 · DOI 10.1177/0022034517744207

Verify or expand the search:

Other trials of Diclofenac sodium

Trials testing the same drug.

Other recruiting trials for Pain

Currently open trials in the same condition.

Other IBSA Institut Biochimique SA trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01706588.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing